Sarepta Therapeutics (SRPT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2005 | 12-2004 | 12-2003 | 12-2002 | 12-2001 | |
| Sales | 4,784 | 431 | 970 | 837 | 706 |
| Gross Profit | 4,784 | 431 | 970 | 837 | 706 |
| Operating Expenses | 22,300 | 25,475 | 19,843 | 26,178 | 16,109 |
| Operating Income | -17,516 | -25,044 | -18,874 | -25,341 | -15,403 |
| Other Income | -690 | 266 | 4,257 | -4,018 | -11,523 |
| Pre-tax Income | -18,206 | -24,778 | -14,617 | -29,359 | -26,925 |
| Net Income Continuous | -18,206 | -24,778 | -14,617 | -29,359 | -26,925 |
| Net Income | $-18,206 | $-24,778 | $-14,617 | $-29,359 | $-26,925 |
| EPS Basic Total Ops | -2.46 | -4.14 | -2.94 | -6.84 | -7.20 |
| EPS Basic Continuous Ops | -2.45 | -4.13 | -2.94 | -6.86 | -7.21 |
| EPS Diluted Total Ops | -2.46 | -4.14 | -2.94 | -6.84 | -7.20 |
| EPS Diluted Continuous Ops | -2.45 | -4.13 | -2.94 | -6.86 | -7.21 |
| EBITDA(a) | $-15,519 | $-23,156 | $-17,389 | $-24,008 | $-14,846 |